𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Body weight in patients with Parkinson's disease

✍ Scribed by Cornelius G. Bachmann; Claudia Trenkwalder


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
75 KB
Volume
21
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

There is some evidence suggesting that Parkinson's disease (PD) patients exhibit lower body weight when compared to age‐matched healthy subjects. Low body mass index (BMI) is correlated with low bone mineral density, both of which are major risk factors for hip fractures. Possible determinants of weight loss in PD patients include hyposmia, impaired hand–mouth coordination, difficulty chewing, dysphagia, intestinal hypomotility, depression, decreased reward processing of dopaminergic mesolimbic regions, nausea, and anorexia as the side effects of medication, and increased energy requirements due to muscular rigidity and involuntary movements. It is unclear whether PD patients in general, or only a subgroup of those affected, definitely show lower BMI in the advanced stages of the disease. We therefore recommend that the body weight of PD patients be monitored monthly as the disease progresses, and that a patient's nutrition should be supplemented with sufficient amounts of vitamin D and calcium to reduce the risk of hip fractures and strengthen bone density. Because mealtimes may coincide with unpredictable off periods associated with akinesia and impaired hand–mouth coordination, PD patients also need flexible food schedules that accommodate the associated symptoms of this disease. Β© 2006 Movement Disorder Society


πŸ“œ SIMILAR VOLUMES


Body weight gain rate in patients with P
✍ Michela Barichella; Agnieszka M. Marczewska; Claudio Mariani; Andrea Landi; Anto πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 1 views

## Abstract We evaluated body weight changes in patients with Parkinson's disease (PD) after electrode implantation for deep brain stimulation (DBS) in the subthalamic nucleus (STN) in relation to clinical improvement. Thirty PD patients who received STN DBS were included (22 men, 8 women; mean age

Increase in body weight after pramipexol
✍ Hatice Kumru; Joan Santamaria; Francesc Valldeoriola; Maria J. Marti; Eduardo To πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

## Abstract Body weight changes occur during the clinical course of Parkinson's disease (PD) and with surgical treatment, but the effect of dopaminergic treatment on weight is unknown. Body mass index (BMI), Hamilton depression scale score (HDS), and Unified Parkinson's Disease Rating Scale III (UP

Weight loss, body fat mass, and leptin i
✍ Birgitta LorefΓ€lt; GΓΆran Toss; Ann-Kathrine GranΓ©rus πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 1 views

## Abstract Weight loss is a common problem in Parkinson's disease (PD), but the causative mechanisms behind this weight loss are unclear. We compared 26 PD patients with sex and age matched healthy controls. Examinations were repeated at baseline, after one and after two years. Body fat mass was m